Sector ratings Divi's Laboratories Limited

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:02 13/04/2026 pm IST			5-day change	1st Jan Change
6,070.00 ^INR	-0.76%		+3.65%	-5.04%

01/04	Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840	MT
12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
DIVI'S LABORATORIES LIMITED	1.75TCr		BB
ELI LILLY AND COMPANY	84TCr		A
JOHNSON & JOHNSON	57TCr		BBB
ABBVIE INC.	37TCr		AA
ROCHE HOLDING AG	32TCr		AA			-		-
ASTRAZENECA PLC	32TCr		A
MERCK & CO., INC.	30TCr		A
NOVARTIS AG	29TCr		AAA
AMGEN INC.	19TCr		A
GILEAD SCIENCES, INC.	17TCr		AA
NOVO NORDISK A/S	17TCr		A
PFIZER INC.	15TCr		A
BRISTOL-MYERS SQUIBB COMPANY	12TCr		A
GSK PLC	12TCr		AA
SANOFI	11TCr		AA
VERTEX PHARMACEUTICALS INCORPORATED	11TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	8.97TCr		AA
ALLERGAN PLC	6.37TCr	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.69TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.54TCr		AA
Average	22.22TCr		AA
Weighted average by Cap.			AA